These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15860552)

  • 1. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
    Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
    J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
    Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.
    Van de Velde S; Nguyen HA; Van Bambeke F; Tulkens PM; Grellet J; Dubois V; Quentin C; Saux MC
    J Antimicrob Chemother; 2008 Sep; 62(3):518-21. PubMed ID: 18544595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
    Lemaire S; Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2011 Jul; 38(1):52-9. PubMed ID: 21596526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ertapenem against selected respiratory pathogens.
    Marchese A; Gualco L; Schito AM; Debbia EA; Schito GC
    J Antimicrob Chemother; 2004 Nov; 54(5):944-51. PubMed ID: 15472001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular accumulation and activity of ampicillin used as free drug and as its phthalimidomethyl or pivaloyloxymethyl ester (pivampicillin) against Listeria monocytogenes in J774 macrophages.
    Chanteux H; Mingeot-Leclercq MP; Sonveaux E; Van Bambeke F; Tulkens PM
    J Antimicrob Chemother; 2003 Oct; 52(4):610-5. PubMed ID: 12972457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin.
    Imbuluzqueta E; Lemaire S; Gamazo C; Elizondo E; Ventosa N; Veciana J; Van Bambeke F; Blanco-Prieto MJ
    J Antimicrob Chemother; 2012 Sep; 67(9):2158-64. PubMed ID: 22615297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections.
    Baudoux P; Bles N; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2007 Feb; 59(2):246-53. PubMed ID: 17220162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
    Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
    Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
    Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin.
    Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Glupczynski Y; Tulkens PM
    Antimicrob Agents Chemother; 2007 May; 51(5):1627-32. PubMed ID: 17307986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.
    Livermore DM; Mushtaq S; Warner M
    J Antimicrob Chemother; 2005 Mar; 55(3):306-11. PubMed ID: 15705643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model.
    Carryn S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
    J Antimicrob Chemother; 2003 Apr; 51(4):1051-2. PubMed ID: 12654747
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.
    Carryn S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2095-103. PubMed ID: 12069960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.
    Rödel R; Freyer A; Bittner T; Schäfer V; Hunfeld KP
    Int J Antimicrob Agents; 2007 Jul; 30(1):83-6. PubMed ID: 17512703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil.
    Kiffer CR; Kuti JL; Eagye KJ; Mendes C; Nicolau DP
    Int J Antimicrob Agents; 2006 Oct; 28(4):340-4. PubMed ID: 16930951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Lemaire S; Olivier A; Van Bambeke F; Tulkens PM; Appelbaum PC; Glupczynski Y
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2797-805. PubMed ID: 18519727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
    Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.